… Therapy of infections caused by extended‐spectrum β‐lactamase (… piperacillin–tazobactam,
when they test as such. Current literature supports the action of piperacillin–tazobactam …

… and piperacillin-tazobactam. Our results suggested that piperacillin-tazobactam can be as
… We were unable to ascertain if all patients received extended infusions. We attempted to …

… dosing strategies of piperacillin-tazobactam against ESBL-producing Enterobacteriaceae.
Given the variability of clinical responses to piperacillin-tazobactam, we hypothesized that the …

… Piperacillin/tazobactam (TZP) as an alternative treatment to carbapenems for infections
involving extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-PE) …

… for the treatment of infections caused by extended-spectrum-beta-lactamase (ESBL)-producing
Gram-negative bacteria (ESBL-GNR). Piperacillin-tazobactam (PTZ) is one of the most …

… comparing carbapenems to piperacillin-tazobactam among patients … A piperacillin-tazobactam
case was defined as a patient who was treated with ≥2 doses of piperacillintazobactam …

β-Lactam resistance on the part of the Enterobacteriaceae causes serious therapeutic
problems in our institutions due to their production of extended-spectrum β-lactamases (ESβLs). …

… The purpose of this study was to compare the clinical efficacy of piperacillin/tazobactam (TZP)
versus ertapenem in the treatment of adult patients with APN caused by ESBL-Ec. A …

… , the resultant combination possesses a broader spectrum of activity … extended if larger
doses are administered. This same strategy has been investigated for other extended spectrum …

… when using extended-infusion piperacillintazobactam in place … with extended-infusion
piperacillin-tazobactam throughout … comparing extended-infusion piperacillin-tazobactam with the …